Glaucoma, Neovascular  >>  Eylea (aflibercept intravitreal)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eylea (aflibercept intravitreal) / Regeneron
VEGA, NCT02396316: Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Completed
3
54
Japan
Aflibercept (Eylea, BAY 86-5321), Sham Injection
Bayer, Regeneron Pharmaceuticals
Glaucoma, Neovascular
06/16
09/16

Download Options